How has been the historical performance of Kashyap TeleMed.?

Answer:The historical performance of Kashyap TeleMed shows a relatively stable but low level of net sales over the years, with figures remaining at 0.19 Cr in both Mar'25 and Mar'24, and slightly higher at 0.20 Cr in Mar'23, Mar'22, and Mar'19. The total operating income has mirrored the net sales, remaining at 0.19 Cr in Mar'25 and Mar'24, while also being 0.20 Cr in the previous years. The company has not incurred any raw material costs, purchase of finished goods, or power costs during this period. Employee costs have increased from 0.05 Cr in Mar'17 to 0.11 Cr in Mar'25, indicating a gradual rise in operational expenses. However, total expenditure (excluding depreciation) peaked at 0.30 Cr in Mar'22 before decreasing to 0.19 Cr in Mar'25. Operating profit has fluctuated, with a loss of 0.03 Cr in Mar'24 and a break-even point in Mar'25, while profit before tax has remained at 0.00 Cr in Mar'25 and Mar'23, with a loss of 0.03 Cr in Mar'24. The profit after tax has also been stagnant, showing a loss of 0.03 Cr in Mar'24 and no profit in the subsequent years. The earnings per share have remained at 0.0 in Mar'25, reflecting the company's ongoing challenges in achieving profitability.

Breakdown:
Kashyap TeleMed's financial performance has been characterized by consistent but low net sales, which have remained stable at 0.19 Cr for the last two years, with a slight increase to 0.20 Cr in the years prior. The company's total operating income has followed a similar trend, indicating no significant growth. Employee costs have gradually increased, suggesting a rise in operational expenses, while total expenditure has seen a notable decrease from 0.30 Cr in Mar'22 to 0.19 Cr in Mar'25. Despite these changes, the company has struggled with profitability, reporting an operating profit of 0.00 Cr in Mar'25 after a loss in the previous year, and consistently low profit before and after tax figures. The earnings per share have not improved, remaining at 0.0 in Mar'25, which reflects the ongoing difficulties in achieving financial stability and growth.